HCV Guidelines and Recommendations
CDC Recommendations for Hepatitis C Screening Among Adults (2020), Centers for Disease Control and Prevention
HCV Continuing Education and Training
Hepatitis C Online, University of Washington
Free online training for diagnosing, monitoring, managing, and preventing hepatitis C virus (HCV) infection.
Project ECHO, University of New Mexico
Nationally recognized education model using adult learning techniques and interactive video technology. The model connects groups of community providers with specialists in regular real-time collaborative sessions. The sessions are designed around case-based learning and mentorship to expand provider capacity at the primary care level to diagnose, treat and manage hepatitis C. States offering Project ECHO training include: Arizona, California, Hawaii, Indiana, Iowa, Louisiana, Michigan, Mississippi, New Mexico, Virginia and Washington.
Hepatitis C Toolkit Curriculum, AIDS Education & Training Center Program
The purpose of this training is to improve providers’ capacity to screen, medically manage, and provide advanced care for patients with hepatitis C virus (HCV).
HCV Clinical Support
Hepatitis C Warmline, University of California San Francisco
The National Clinician Consultation Center offers free, real-time clinician-to-clinician telephone consultations to healthcare providers who are treating hepatitis C.
HCV Quick Reference Tools
Viral Hepatitis Guide for Primary Care Providers, California Department of Public Health
This guide for primary care providers includes guidance on HAV, HBV, and HCV screening, vaccination, and billing.
Hepatitis C Provider Pocket Guide, Swope Health
This hepatitis C pocket guide for healthcare providers was developed by Dr. Rachel Melson, DNP, FNP-C, Hepatitis C Program Director at Swope Health. This customizable guide includes screening and treatment guidelines, care navigation tips, and harm reduction resources. You can design your own version of this pocket guide using this Canva template. Of note, pages 2 and 13 should not be edited.
HEP Drug Interaction Checker, University of Liverpool
A clinically useful, reliable, comprehensive, up-to-date, evidence-based drug-drug interaction resource, freely available to healthcare workers, patients and researchers managing hepatitis medications.
A Pragmatic Guide for Primary Care Practitioners: The Diagnosis and Treatment of Patients with Hepatitis C Virus, MedStar
This guide was designed for providers who are interested in improving the early diagnosis of HCV and the frequency with which patients diagnosed with HCV area treated in the primary care setting.
HCV Current Initiative, Addiction Technology Transfer Center Network (ATTC)
A national initiative to increase hepatitis C (HCV) knowledge among medical and behavioral health professionals by providing online and in-person curriculum and training, downloadable provider tools, and region-specific resources, including a Guide to Integrating HCV Services into Opioid Treatment Programs.
HCV.com, AbbVie Medical Affairs
An educational site dedicated to providing information and resources to healthcare providers who want to learn more about hepatitis C.
Hepatitis C Screening Promotional Materials, Mount Sinai
Flyers, postcards, and electronic medical record message templates to promote hepatitis C screening among patients and providers.
HCV Treatment Access Support
Hepatitis C: State of Medicaid Access
Led by NVHR and the Center for Health Law and Policy Innovation, this project tracks prior authorization requirements for HCV treatment across state Medicaid programs. For support with advocating to remove prior authorization requirements, check out our resources. If you are experiencing difficulties with prescribing treatment through your state’s Medicaid program, contact us here.
HCV Financial Assistance
Manufacturer Assistance Programs
AbbVie provides copay assistance for Mavyret. Co-pay assistance is available to patients who meet the income requirements and have private insurance. Free medication will be provided to those who are uninsured.
Gilead Support Path
Gilead provides copay assistance for Epclusa, Harvoni, Vosevi, sofosbuvir/velpatasvir, and ledipasvir/sofosbuvir. Co-pay assistance is available to patients who meet the income requirements and have private. Free medication will be provided to those who are uninsured.
Non-Profit Assistance Programs
Good Days provides co-pay assistance for HCV treatment as funds are available. The maximum award level is $15,000 annually and patients must have a household income of 500% or less of the federal poverty level.
The HealthWell Foundation provides co-pay and premium assistance for HCV treatment as funds are available. The maximum award level is $30,000 annually and patients must have a household income of 500% or less of the federal poverty level.
Link 2 Labs is an online lab company that offers discounted lab tests for hepatitis C, HIV, and STIs to patients who are underinsured or uninsured.
NeedyMeds is a non-profit organization whose mission is to help people who cannot afford their hepatitis C medication. They offer a patient assistance program database that provides a list of patient assistance programs and services offered.
Patient Assistance for Lab Services (PALS)
PALS is a division of Missouri-based HepC Alliance; a non-profit organization working to assist those at risk or are positive for hepatitis C. PALS offers over 300 commonly ordered blood test at a discounted price.
Patient Advocate Foundation Co-Pay Relief
The Patient Advocate Foundations offers two co-pay relief programs as funding is available: Hepatitis C and Hepatitis C Health Equity. Direct Financial Assistance up to $15,000 annually is provided to qualified patients. Fund types include co-pay, co-insurance, deductibles, office visits, administration charges related to treatment and medical insurance premiums. The programs are available for all insurance types so long as the member meets the income requirement of 400% or less of Federal Poverty Guideline.
Patient Access Network Foundation
The PAN Foundation provides co-pay for HCV treatment as funds are available. The maximum award level is $5,600 annually and patients must have a household income of 500% or less of the federal poverty level.
The Assistance Fund (TAF)
TAF provides co-pay assistance for HCV treatment as funds are available. Copay programs provide financial assistance for out-of-pocket costs for prescribed FDA-approved treatment, such as copays, deductibles, and coinsurance.